UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment

Journal of ethnopharmacology, 2017-01, Vol.196, p.281-292

2017

Volltextzugriff (PDF)

Network Proximity Analysis Deciphers the Pharmacological Mechanism of Osthole against D-Galactose Induced Cognitive Disorder in Rats

Molecules (Basel, Switzerland), 2023-12, Vol.29 (1), p.21

2023

Volltextzugriff (PDF)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease

Frontiers in pharmacology, 2020-04, Vol.11, p.381-381

2020

Volltextzugriff (PDF)

The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease

Scientific reports, 2018-02, Vol.8 (1), p.3104-13, Article 3104

2018

Volltextzugriff (PDF)

Corrigendum to “Associations of dichlorophenols, trichlorophenols, and ortho-phenylphenol with the risk and prognosis of diabetes and prediabetes: A population-based study” [Ecotoxicol. Environ. Saf. 277 (2024) 116345]

Ecotoxicology and environmental safety, 2024-07, Vol.279, p.116477-116477, Article 116477

2024

Volltextzugriff (PDF)

Associations of dichlorophenols, trichlorophenols, and ortho-phenylphenol with the risk and prognosis of diabetes and prediabetes: A population-based study

Ecotoxicology and environmental safety, 2024-06, Vol.277, p.116345-116345, Article 116345

2024

Volltextzugriff (PDF)

Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol

Frontiers in neuroscience, 2022-04, Vol.16, p.842814-842814

2022

Volltextzugriff (PDF)

Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways

Cell biology and toxicology, 2021-02, Vol.37 (1), p.113-128

2021

Volltextzugriff (PDF)

Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats

Chinese medicine, 2023-05, Vol.18 (1), p.53-53, Article 53

2023

Volltextzugriff (PDF)

Combination of pigment epithelium‐derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis

Cancer science, 2011-10, Vol.102 (10), p.1789-1798

2011

Volltextzugriff (PDF)

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease

Frontiers in pharmacology, 2023-10, Vol.14, p.1239060-1239060

2023

Volltextzugriff (PDF)

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease

Frontiers in pharmacology, 2022-05, Vol.13, p.904857-904857

2022

Volltextzugriff (PDF)

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease

BMC complementary medicine and therapies, 2020-09, Vol.20 (1), p.282-15, Article 282

2020

Volltextzugriff (PDF)

Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD

Molecular therapy. Nucleic acids, 2020-06, Vol.20, p.140-154

2020

Volltextzugriff (PDF)

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease

Computational and structural biotechnology journal, 2023-01, Vol.21, p.1907-1920

2023

Volltextzugriff (PDF)

Overexpression of Histone Deacetylase and Amyloid Precursor Protein in Hepatocellular Carcinoma

Technology in cancer research & treatment, 2017-10, Vol.16 (5), p.586-594

2017

Volltextzugriff (PDF)

(−)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein

Medical oncology (Northwood, London, England), 2015-01, Vol.32 (1), p.390-390, Article 390

2015

Volltextzugriff (PDF)

Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson’s Disease

ACS applied materials & interfaces, 2019-12, Vol.11 (48), p.45276-45289

2019

Volltextzugriff (PDF)

Overexpression of thioredoxin‐2 attenuates age‐related muscle loss by suppressing mitochondrial oxidative stress and apoptosis

JCSM rapid communications, 2022-01, Vol.5 (1), p.130-145

2022

Volltextzugriff (PDF)

Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy

Molecular pharmaceutics, 2019-04, Vol.16 (4), p.1444-1455

2019

Volltextzugriff (PDF)

Association between trichlorophenols and neurodegenerative diseases: A cross-sectional study from NHANES 2003–2010

Chemosphere (Oxford), 2022-11, Vol.307 (Pt 2), p.135743, Article 135743

2022

Volltextzugriff (PDF)

Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss

Phytomedicine (Stuttgart), 2021-10, Vol.91, p.153662, Article 153662

2021

Volltextzugriff (PDF)

Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective

Food and chemical toxicology, 2020-11, Vol.145, p.111767-111767, Article 111767

2020

Volltextzugriff (PDF)

Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer's disease using UPLC-Q-TOF-MS, network analysis, and experimental validation

European journal of pharmacology, 2023-09, Vol.954, p.175895-175895, Article 175895

2023

Volltextzugriff (PDF)

Modulating endoplasmic reticulum stress in APP/PS1 mice by Gomisin B and Osthole in Bushen-Yizhi formula: Synergistic effects and therapeutic implications for Alzheimer's disease

Phytomedicine (Stuttgart), 2023-10, Vol.119, p.155023-155023, Article 155023

2023

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(32)
Animals
(17)
Alzheimer's Disease
(16)
Humans
(14)
Alzheimer’s Disease
(10)
Apoptosis
(9)
Mice
(9)
Pharmacology & Pharmacy
(8)
Proteins
(8)
Cell Biology
(7)
Male
(7)
Pharmacology
(7)
Technology
(7)
Integrative & Complementary Medicine
(6)
Neurodegenerative Diseases
(6)
Oncology
(6)
Physical Sciences
(6)
Rats
(6)
Alzheimer Disease - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment

Network Proximity Analysis Deciphers the Pharmacological Mechanism of Osthole against D-Galactose Induced Cognitive Disorder in Rats

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease

The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer's Disease

Corrigendum to “Associations of dichlorophenols, trichlorophenols, and ortho-phenylphenol with the risk and prognosis of diabetes and prediabetes: A population-based study” [Ecotoxicol. Environ. Saf. 277 (2024) 116345]

Associations of dichlorophenols, trichlorophenols, and ortho-phenylphenol with the risk and prognosis of diabetes and prediabetes: A population-based study

Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol

Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways

Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats

Combination of pigment epithelium‐derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease

Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease

Aberrant Expression Profiles of lncRNAs and Their Associated Nearby Coding Genes in the Hippocampus of the SAMP8 Mouse Model with AD

Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease

Overexpression of Histone Deacetylase and Amyloid Precursor Protein in Hepatocellular Carcinoma

(−)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein

Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson’s Disease

Overexpression of thioredoxin‐2 attenuates age‐related muscle loss by suppressing mitochondrial oxidative stress and apoptosis

Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy

Association between trichlorophenols and neurodegenerative diseases: A cross-sectional study from NHANES 2003–2010

Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss

Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective

Systems pharmacology-based mechanism exploration of Acanthopanax senticosusin for Alzheimer's disease using UPLC-Q-TOF-MS, network analysis, and experimental validation

Modulating endoplasmic reticulum stress in APP/PS1 mice by Gomisin B and Osthole in Bushen-Yizhi formula: Synergistic effects and therapeutic implications for Alzheimer's disease

Suchergebnisse filtern